RETRACTED: Cheng et al. High PGC-1α Expression as a Poor Prognostic Indicator in Intracranial Glioma. Biomedicines 2024, 12, 979 Authors: Yu-Wen Cheng, Jia-Hau Lee, Chih-Hui Chang, Tzu-Ting Tseng, Chee-Yin Chai, Ann-Shung Lieu, Aij-Lie Kwan Published: 2025 The journal retracts the article “High PGC-1α Expression as a Poor Prognostic Indicator in Intracranial Glioma” [1] cited above. Following publication, concerns were brought to the attention of the publisher regarding a partial overlap of images presented in this article [1]. Adhering to our complaint’s procedure, an investigation was conducted that confirmed a partial duplication within Figure 5, presenting different experimental conditions. While the authors cooperated with the Editorial Office during the investigation, they were unable to satisfactorily explain the similarities within Figure 5, nor provide raw material for the Editorial Board to review. As a result, the Editorial Board has lost confidence in the reliability of the findings and has decided to retract this publication [1], as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30). This retraction was approved by the Editor-in-Chief of the Biomedicines journal. The authors disagree with this retraction.